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Monday, February 4, 2013 275aion unbinding and interface opening is observed for a mutant (L783S) where
the cation site is indirectly disrupted by disturbing a hydrophobic plug shielding
the site. In the electrophysiological studies, this mutant appears non-functional.
Overall, the results are consistent with the view that maximum conductance de-
pends on a tightly packed dimer-interface regulated by the presence of extracel-
lular ions.
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Details of GABA Binding to the GABA-A Receptor Revealed by Molecular
Dynamics
Tim S. Carpenter, Felice C. Lightstone.
Lawrence Livermore Natl Lab, Livermore, CA, USA.
Through the analysis of two rare-event molecular dynamics simulations, we
were able to observe the complete dissociation of a GABA molecule from
the GABAA-receptor, the diffusion of that molecule into bulk water, and
then the subsequent re-binding of GABA into its binding pocket.
The route for this re-binding event was not linear in fashion, but rather adopted
‘bind, slide, and find’ approach. We found that the GABA molecule BINDS to
the protein surface outside of the binding pocket, SLIDES along the protein sur-
face into the pocket itself, and then FINDS the correct binding orientation once
it is within the binding pocket.
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Exome sequencing of ion channel genes from cases with well characterized id-
iopathic generalized epilepsies (IGEs) has identified many rare, nonsynony-
mous single nucleotide polymorphysms (nSNPs) in the human non-epilepsy
genes GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRG1 and
GABRG3. Structural homology modeling predicts that the rare variants are
mainly localized between the agonist-binding domain (N-terminus) and the
channel gate (transmembrane domain, TM) of GABAA receptor subunits.
We sought to investigate the effects of the rare nSNPs on assembly and function
of GABAA receptors containing one of seven separate IGE-associated rare var-
iants identified in a5 and b2 subunits (a5V204I, W280R, S402A, P453L,
A459T; b2R293W, R354C), which are located within the well-defined struc-
tural GABAA receptor domains. We studied gating properties and surface ex-
pression of wild-type (wt) a5b3g2, a1b2g2 and mutant (mut) a5(mut)b3g2,
a1b2(mut)g2 receptors expressed in HEK293T cells. We found that variants
located within the N-terminal domain and in the juxtamembrane interface dis-
played gating or mixed gating and trafficking defects. Furthermore, variants
within TMs displayed trafficking defects, but those within the cytoplasmic
loop had no defect. Thus, variant subunits a5V204I and b2R293W displayed
a mixed profile, causing both gating and trafficking defects of a5b3g2 and
a1b2g2 receptors, whereas variant a5W280R subunit caused primarily im-
paired trafficking of a5b3g2 receptors. Interestingly, homology modeling pre-
dicted that a5W280R and b2R293W variants stabilize new hydrogen bonds
across the b/a subunit interface, which seems to be essential for inter-subunit
interactions in assembled receptors. These findings suggest that gating and/or
trafficking defects might suggest that a specific variant may be a susceptibility
gene and may help to predict functional risk for loss of GABAergic function in
individual IGE cases.
NIH funding NS33300 to Robert Macdonald.
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Partial agonists are unable to elicit full maximal responses. The characteriza-
tion of a genuine partial agonist is complex because other mechanisms, such
as channel block, may also limit maximum open probability. Taking advantage
of the high conductance form of the 5-HT3A receptor, we evaluated at the
single-channel level its activation by 2-Me-5HT and tryptamine, which have
been classically considered as partial agonists of 5-HT3 receptors. For all li-
gands, activation appears as openings in quick succession grouped in clusters
showing high open probability (Popen>0.9), and open time distributions
show three components. The slowest open component is 6.5- and 3.5-fold
briefer for 2-Me-5HT and tryptamine, respectively, than for 5-HT. The duration
of this component decreases as a function of agonist concentration due toopen-channel block. For 2-Me-5HT, the forward blocking rate is 10-fold faster
than for tryptamine and 5-HT. Single-channel kinetic analysis shows that
2-Me-5HT is actually a full agonist, its maximum response being limited by
channel block. In contrast, tryptamine is a genuine partial agonist and its low
efficacy is mainly due to a slow transition from the fully-liganded closed state
to a pre-open state. After reaching the latter state, activation proceeds similarly
as in the presence of 5-HT. Molecular docking shows that interactions at the
binding site are similar for 2-Me-5HT and 5-HT. In contrast, the potential to
form the cation-Pi interaction with W183 seems to be reduced for tryptamine.
The mechanism by which ligands produce non maximal responses has implica-
tions for the design of partial agonists for therapeutic use.
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The two neuromuscular acetylcholine receptor (AChR) transmitter binding
sites are located in the extracellular domain of the protein at the a-ε and a-d
subunit interfaces. At each site there are two vicinal prolines in the complimen-
tary ε/d subunit (ProD1 and ProD2). We estimated for dozens of mutations of
ε/d ProD1 and ProD2 (single-channels, HEK cells,þ100mV, 23 oC) the gating
energies with AChmolecules bound (G2 and G1) and without any agonist (G0).
From these we calculated the energy for gating arising from the affinity change
for ACh (GB1þGB2=G2-G0). Mutation of ProD2 had larger effects than of
ProD1. The εProD2-L mutation, which causes a congenital myasthenic syn-
drome, increases aGB (þ3.4 kcal/mol, throughout) but does not change G0.
For the same mutation in the d subunit the change in GB was smaller
(þ1.9). All of the side chain substitutions at ε/dProD2 increased both GB
and G0 compared to the wild-type (which has the values 5.1 and þ8.4).
The largest increase in aGB was for εProD2-R (þ4.7) and in G0 for
dProD2-Q (þ2.5). We used mutant cycle analysis to estimate aGB: coupling
between side chains. The two ProD2 residues interact weakly with each other
(0.6), but there is a strong interaction between εProD2-aGlyB1 (þ2.7) but not
between dProD2- aGlyB2. It is possible that a concerted, Pro-Gly ‘switch’ at
a-ε occurs near to the onset of channel-opening. We engineered AChRs having
only one functional binding site and quantified GB(ACh) for either the a-ε (by
using the dProD2-R knockout or a-d (by using the εProD2-R knockout) site.
The sites provide þ5.2 and 4.7 kcal/mol with ACh. One-site AChRs will
be useful for studying the energy sources for gating by agonists at the two dif-
ferent binding sites.
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Entry of calcium ions through nicotinic acetylcholine receptors hyperpolarizes
outer hair cells (OHCs) by activating colocalized SK potassium channels. This
process, termed efferent inhibition, plays a central role in the protective reflex
by suppressing the amplification of incoming sound. OHC nicotinic receptors
are composed of a9 and a10 subunits that are activated by acetylcholine
(ACh) release from efferent neurons originating within the medial olivoco-
chlear nucleus. Fast application of ACh to GH4C1 cells transiently transfected
with plasmids encoding mouse a9 and a10 subunits, produced an inward cur-
rent that displayed a concentration-dependent amplitude, with an EC50 of 415
5.4 mM and Hill slope (n H) of 0.895 0.1 (n=5). This current was antagonized
by nicotine, displaying a KB of 9.0 5 1.0 mM (n=8), consistent with the
ACh-mediated current arising from activation of heteromeric a9a10 receptor
channels. Inward ACh currents in the presence of the dihydropyridine antago-
nist nimodipine (10 mM) were reduced in amplitude and displayed faster decay
kinetics. Exponential decay rates (t) increased from 647.55 66.0 ms (n=6) in
control, to 160.6 5 25.8 ms (n=6) in the presence of nimodipine (10 mM)
(p<0.0005). The concentration-response relationship to ACh was not signifi-
cantly affected by nimodipine, displaying an EC50 of 28 5 6.7 mM and Hill
slope (n H) of 1.28 (n=5) (p>0.05), suggesting that the increased decay rate
of ACh currents did not result from a decrease in agonist binding affinity. using
a double-pulse protocol, ACh (300 mM)-mediated responses recovered from
desensitization with an exponential time-course (t = 3.81 5 0.67 s, n=3).
Recovery was slowed in the presence of nimodipine (t = 8.88 5 2.54 s;
n=3), indicating that nimodipine stabilizes the desensitization state of the
a9a10 receptor and suggests that these receptors can be modulated to fine-
tune efferent inhibition.
